Biologics Supplier for Medspas and Dermatology in Lexington, KY

Account Eligibility Tied to Physician Supervision

A medspa account is generally anchored to the NPI of its supervising or medical director physician rather than the business entity, since medspas operate under physician supervision rather than their own independent license. Dermatology and plastic surgery practices typically register under the treating physician's own NPI directly.

Confirming which physician's NPI will anchor the account before submitting a request speeds up verification.

Supplier Review Before the First Order

Dermatology groups, plastic surgery practices, and medspas already sourcing other regulated products tend to apply a familiar standard to a new biologics vendor: HCT/P registration status, donor screening and testing descriptions, and a sample certificate of analysis reviewed before the first purchase.

Multi-location dermatology groups in Kentucky often route this review through a compliance manager, while single-physician medspas may complete it more quickly.

Shipping and Storage

Cryopreserved Wharton's jelly products ship overnight on dry ice and require -80 degree C storage on arrival, so freezer capacity should be confirmed before the first order. Lyophilized exosome products are shelf-stable under normal storage conditions per the supplier and do not need a cryogenic freezer, which is often a simpler fit for a medspa without cold-chain infrastructure already in place.

Documentation and Verifying Regulatory Posture

A certificate of analysis, donor eligibility summary, and unique lot identifier accompany every order and are available to verified accounts. Wharton's jelly products are offered under the supplier's HCT/P framework, and whether a specific intended use qualifies under 21 CFR 1271.10 is a determination for the practice and its counsel, not Precision Biologics.

Exosome products are not FDA approved and are generally regulated as biologic drugs. Medspas and dermatology practices in Lexington should verify their intended use with the Kentucky Board of Medical Licensure and their own legal counsel.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.